GLP-1 receptor agonists’ impact on cardio-renal outcomes and mortality in T2D with acute kidney disease
Heng‐Chih Pan(National Taiwan University), Vin‐Cent Wu(National Taiwan University Hospital)
Cited by 65
Related Papers
The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes
|Scientific Reports|2017|93
Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort
|The Lancet Diabetes & Endocrinology|2025|53
Impact of SGLT2 inhibitors on patient outcomes: a network meta-analysis
|Cardiovascular Diabetology|2023|39
Acute kidney injury in patients with COVID-19 compared to those with influenza: a systematic review and meta-analysis
|Frontiers in Medicine|2023|5
Immune checkpoint inhibitors-associated acute kidney injury: a systematic review and meta-analysis of incidence, kidney recovery, and recurrent risk
|Cancer Immunology Immunotherapy|2025|3